Abstract
Glutamate plays a central role in the excitatory synaptic transmission and is important for brain development and functioning. Increased glutamate levels in the synaptic cleft are related to neuronal damage associated with excitotoxicity. Guanidinoacetate methyltransferase (GAMT) deficiency is an inherited neurometabolic disorder biochemically characterized by tissue accumulation of guanidinoacetate (GAA) and depletion of creatine. Affected patients present epilepsy and mental retardation whose pathogeny is unclear. In the present study we investigated the in vitro and in vivo (intrastriatal administration) effect of GAA on glutamate uptake by striatum slices of developing and adult rats. Results showed that GAA significantly inhibited in vitro glutamate uptake at 50 μM and 100 μM in all ages tested. We also tested the effect of taurine on the inhibition of glutamate uptake caused by GAA. Taurine significantly attenuated the inhibitory effect caused by 50 μM GAA, but did not alter that provoked by 100 μM GAA. Furthermore, intrastriatal administration of a solution of 30 μM GAA (0.06 nmol/striatum) significantly inhibited glutamate uptake by rat striatum slices. Our results suggest that the inhibition of striatal glutamate uptake caused by GAA might be involved in the neuropathology and especially in the acute neurological features present in patients with GAMT-deficiency.
Similar content being viewed by others
References
Von Figura K, Hanefeld F, Isbrandt D, Stöckler-Ipsiroglu S (2001) Guanidinoacetate methyltransferase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1897–1908
Leuzzi V, Bianchi MC, Tosetti M, Carducci C, Cerquiglini CA, Cioni G, Antonozzi I (2000) Brain creatine depletion: guanidinoacetate methyltransferase deficiency (improving with creatine supplementation). Neurology 55:1407–1409
Schulze A, Ebinger F, Rating D, Mayaetepek E (2001) Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 74:413–419
Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105
Segovia G, Porras A, Del Arco F, Mora F (2001) Glutamatergic neurotransmission in aging: a critical perspective. Mech Ageing Dev 122:1–29
Maragakis NJ, Rothstein JD (2004) Glutamate trasporters: animal models to neurologic disease. Neurobiol Dis 15:461–473
Friedler RM (2003) Apoptosis and caspases in neurodegenerative diseases. N Engl J Méd 48:1365–1375
Chen Y, Swnason RA (2003) Astrocytes and brain injury. J Crerbr Blood F Met 23:137–149
Della Corte L, Crichton RR, Duburs G, Nolan K, Tipton KF, Tirzitis G, Ward RJ (2002) The use of taurine analogues to investigate taurine functions and their potential therapeutic applications. Amino Acids 23:367–379
Gupta RC, Win T, Bittner S (2005) Taurine analogues; a new class of therapeutics: retrospect and prospects. Curr Med Chem 12:2021–2039
Wang JX, Li Y, Zhang LK, Zhao J, Pang YZ, Tang CS, Zhang J (2005) Taurine inhibits ischemia/reperfusion-induced compartment syndrome in rabbits. Acta Pharmacol Sin 26:821–827
Zugno AI, Franzon R, Chiarani F, Bavaresco CS, Wannmacher CMD, Wajner M, Wyse ATS (2004) Evaluation of the mechanism underlying the inhibitory effect of guanidinoacetate on brain Na+, K+-ATPase activity. Int J Devl Neuroscience 22:191–196
Qi B, Yamagami T, Naruse Y, Kagamimori S (1995) Effects of taurine on depletion of erythrocyte membrane Na+, K+-ATPase activity due to ozone exposure or cholesterol enrichment. J Nutr Sci Vitaminol 41:627–634
Folbergrova J, Haugvicova R, Mares P (2001) Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonosts. Brain Res 980:120–129
Zugno AI, Scherer EBS, Schuck PF, Oliveiram DL, Wofchuk S, Wannmacher CMD, Wajner M, Wyse ATS (2006) Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatum. Met Brain Dis (in press)
Thomazi AP, Godinho GFRS, Rodrigues JM, Schwalm FD, Frizzo MES, Moriguchi E, Souza DO, Wofchuk ST (2004) Ontogenetic profile of glutamate uptake in brain structures slices from rats: sensitivity to guanosine. Mech Ageing and Dev 125:475–481
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–267
Saransaari P, Oja SS (2000) Taurine and neural cell damage. Amino acids 19:509–526
Maragakis NJ, Rothstein JD (2001) Glutamate transporters in neurologic disease. Arch Neurol 58:365–370
Mori A, Kohno M, Masumizu T, Nosa Y, Packer I (1996) Guanidino compounds generate reactive oxygen species. Biochem Mol Biol Int 40:135–143
Hiramatsu M (2003) A role for guanidino compounds in the brain. Mol Cell Biochem 244:57–62
Begni B, Brighina L, Sirtori E, Fumagalli L, Andreoni S, Beretta S, Oster T, Malaplate-Armand C, Isella V, Appolonio I, Ferrarese C (2004) Oxidatibe stress impairs glutamate uptake in fibroblasts from patients wuth Alzheimer´s disease. Free Rad Biol Med 37:892–901
Sala G, Beretta S, Ceresa C, Mattavelli L, Zoia C, Tremolizzo L, Ferri A, Carrı MT, Ferrarese C (2005) Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu, Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis. Neurochem Int 46:227–234
Szatkowski M, Barbour B, Attwell D (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 348:443–446
Attwell D, Barbour B, Szatkowski M (1993) Nonvesicular release of neurotransmitter. Neuron 11:401–407
Rossi DJ, Oshima T, Attwell D (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403:316–321
Fariello RG, Golden GT, Pisa M (1982) Homotaurine (3-aminopropanesulfonic acid; 3APS) protects from the convulsivant and cytotoxic effect systemically administered kainic acid. Neurology 32:241–245
French ED, Venazzi A, Whetsell WO Jr, Schwarcz R (1986) Antiexcitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. Adv Exp Med Biol 203:349–362
Trenkner E (1990) The role of taurine and glutamate during early postnatal cerebellar development of normal and weavermutant mice. Adv Exp Med Biol 268:239–244
Petrosian AM, Haroutounian JE (2000) Taurine as a universal carrier of lipid soluble vitamins: a hypothesis. Amino acids 19:409–421
Kontro P, Oja SS (1987) Taurine and GABA release from mouse cerebral cortex slices: effectes of structural analogues and drugs. Neurochem Res 12:475–482
Frosini M, Sesti C, Dragoni S, Valoti M, Palmi M, Dixon HBF, Machetti F, Sgaragli G (2003) Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain. Brit J Pharmaco 138:1163–1171
Di Leo MA, Mantini SA, Cercone S, Lepore D, Gentiloni Silveri N, Caputo S, Grecco AV, Giardina B, Franconi F, Ghirlanda G (2002) Chronic taurine supplementation ameliorates oxidative stress and Na+, K+-ATPase impairment in the retina of diabetic rats. Amino acids 23:401–406
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zugno, A.I., Oliveira, D.L., Scherer, E.B.S. et al. Guanidinoacetate Inhibits Glutamate Uptake in Rat Striatum of Rats at Different Ages. Neurochem Res 32, 959–964 (2007). https://doi.org/10.1007/s11064-006-9245-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-006-9245-1